IMMUNITYBIO, INC. Public Float
IMMUNITYBIO, INC. (IBRX) had Public Float of $690.20 million as of 2025-06-30, per its 10-K filed 2026-02-23.
Financial Statements › Notes › Cover Page
dei:EntityPublicFloat · last filed 2026-02-23
- 2025-06-30: Entity Public Float $690.20M.
- 2024-06-28: Entity Public Float $980.30M.
- 2023-06-30: Entity Public Float $315.90M.
- 2022-06-30: Entity Public Float $302.10M.
| Period end | Entity Public Float |
|---|---|
| 2025-06-30 | $690.20M 10-K · filed 2026-02-23 |
| 2024-06-28 | $980.30M 10-K · filed 2025-03-03 |
| 2023-06-30 | $315.90M 10-K · filed 2024-03-19 |
| 2022-06-30 | $302.10M 10-K · filed 2023-03-01 |
| 2021-06-30 | $1.05B 10-K · filed 2022-03-01 |
| 2020-06-30 | $415.40M 10-K · filed 2021-03-04 |
| 2019-06-30 | $28.80M 10-K · filed 2020-03-25 |
| 2018-06-30 | $86.10M 10-K · filed 2019-03-13 |
| 2017-06-30 | $208.30M 10-K · filed 2018-03-12 |
| 2016-06-30 | $185.40M 10-K · filed 2017-03-15 |
| 2015-07-28 | $961.50M 10-K · filed 2016-03-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Kymera Therapeutics, Inc. (KYMR) | United States | $9.631B | -31.69 |
| Vaxcyte, Inc. (PCVX) | United States | $8.466B | -7.91 |
| Krystal Biotech, Inc. (KRYS) | United States | $10.210B | 45.56 |
| REPLIGEN CORP (RGEN) | United States | $10.755B | 185.31 |
| Immunovant, Inc. (IMVT) | United States | $7.028B | -14.78 |
| BIO-TECHNE Corp (TECH) | United States | $11.379B | 74.68 |
| Twist Bioscience Corp (TWST) | United States | $11.540B | -47.21 |
| CG Oncology, Inc. (CGON) | United States | $6.095B | -27.95 |
| Scholar Rock Holding Corp (SRRK) | United States | $5.920B | -16.37 |
| CRISPR Therapeutics AG (CRSP) | $5.390B | -11.68 |